UCB
UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, specializing in the discovery and development of innovative medicines and solutions for people living with severe diseases of the immune system or the central nervous system. With a workforce of approximately 9,000 people operating in nearly 40 countries, the company is a major player in the pharmaceutical industry, particularly in the fields of neurology and immunology. In Spain, UCB operates through its subsidiary UCB Iberia, with its main headquarters located in Madrid. The company is known for its collaborative work environment and commitment to patient-centric innovation, making it an attractive destination for international professionals in the life sciences sector. While many roles require Spanish proficiency for local market engagement, the company's global nature offers opportunities for cross-border collaboration and career development within a multinational framework.
Company History
Founded in 1928 by Emmanuel Janssen, UCB originally focused on industrial chemicals before transitioning into a research-driven biopharmaceutical leader. Over the decades, it has expanded globally through strategic acquisitions and a focus on breakthrough treatments for epilepsy and autoimmune diseases.
For International Professionals
- Global biopharmaceutical leader headquartered in Brussels, Belgium.
- Spanish operations are centered in Madrid, serving the entire Iberia region.
- Focuses on high-growth therapeutic areas including neurology and immunology.
- Offers a multinational corporate culture with potential for international career mobility.
- Strong emphasis on research and development with a patient-centric approach.